首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   652篇
  免费   37篇
  国内免费   7篇
耳鼻咽喉   11篇
儿科学   62篇
妇产科学   48篇
基础医学   62篇
口腔科学   10篇
临床医学   33篇
内科学   109篇
皮肤病学   5篇
神经病学   84篇
特种医学   153篇
外科学   33篇
综合类   6篇
预防医学   40篇
眼科学   3篇
药学   19篇
肿瘤学   18篇
  2023年   3篇
  2021年   6篇
  2020年   4篇
  2019年   7篇
  2018年   10篇
  2017年   4篇
  2016年   5篇
  2015年   7篇
  2014年   7篇
  2013年   12篇
  2012年   15篇
  2011年   14篇
  2010年   22篇
  2009年   12篇
  2008年   12篇
  2007年   29篇
  2006年   26篇
  2005年   17篇
  2004年   23篇
  2003年   23篇
  2002年   21篇
  2001年   19篇
  2000年   18篇
  1999年   10篇
  1998年   31篇
  1997年   23篇
  1996年   27篇
  1995年   26篇
  1994年   17篇
  1993年   19篇
  1992年   3篇
  1991年   5篇
  1990年   8篇
  1989年   16篇
  1988年   18篇
  1987年   14篇
  1986年   12篇
  1985年   22篇
  1984年   11篇
  1983年   14篇
  1982年   23篇
  1981年   11篇
  1980年   14篇
  1978年   6篇
  1977年   12篇
  1976年   12篇
  1975年   5篇
  1968年   3篇
  1958年   3篇
  1955年   2篇
排序方式: 共有696条查询结果,搜索用时 31 毫秒
1.
2.
BACKGROUND: Toxic epidermal necrolysis (TEN) is a severe and potentially fatal drug reaction characterized by an extensive skin rash with blisters and exfoliation, frequently accompanied by mucositis. The wounds caused by TEN are similar to second-degree burns and severe cases may involve large areas of skin loss. OBJECTIVES: Analysis of our results in patients with TEN and evaluation of the variety of therapeutic interventions that has been studied and suggested in TEN. PATIENTS/METHODS: Retrospective analysis of 19 consecutive patients with TEN treated in our burns centre between 1989 and 2004. RESULTS: Immediate withdrawal of any potentially fatal drug, maximum supportive care, and a restricted and tailored antibiotic, medical and surgical treatment regimen confined mortality to 21%, whereas prognosis scores like APACHE II and SCORTEN predicted mortality of 22 and 30%, respectively. A positive contribution of selective digestive decontamination is suggested but has yet to be established. CONCLUSIONS: Because of a potentially fatal outcome, fast referral of a patient suspected of TEN to a specialized centre (mostly a burns unit or specialized dermatology centre) for expert wound management and tailored comprehensive care is strongly advised and contributes to survival.  相似文献   
3.
1背景 育龄妇女常见慢性下腹痛,可造成身体损害、情绪忧伤及导致巨大的健康服务费用。美国在这方面的花费超过8亿8千万美元(Mathias 1996)。英国全国数据库的一般性诊治资料显示,慢性下腹痛发病率及流行率与偏头痛、背部痛、哮喘发病率相似(Zondervan 1999)。  相似文献   
4.
5.
Acute vascular occlusion after percutaneous transluminal coronary angioplasty (PTCA) often necessitates a prompt aortocoronary bypass-operation (CABG). Alternatively, a re-PTCA can be attempted. In 1500 consecutive patients there was acute symptomatic occlusion due to PTCA 5 min to 16 h after the operation in 47 cases (3.1%). An immediate re-PTCA was attempted in all cases. Results: Reopening was successful in 43 of 47 cases (91%): in 15 patients (30%) within 30 min, in 36 patients (68%) within 60 min and in 42 patients (89%) within 90 min. In eight patients there was early re-occlusion 30 min to 20 h after re-PTCA, necessitating acute CABG in four patients. In 35 patients with re-PTCA the vessel remained open. Re-stenosis occurred within 1 to 10 days in 10 patients, and in additional 12 patients after 2-4 months. In most cases an additional PTCA was successful. Complications: Six patients had an emergency CABG (three with an exchange wire as a stent in the dissected coronary artery). Three patients died (one after CABG); 14 patients experienced myocardial infarction (30%) (in three of these 14 the infarct was large). Conclusion: Acute vascular occlusion after PTCA can successfully be treated by re-PTCA in four of five cases. However a rate of re-stenosis of about 60% is to be anticipated. Reperfusion with re-PTCA is fast and in these patients with transmural ischemia there are obviously less complications in comparison to emergency CABG after PTCA. 60% of the patients remain symptom free or markedly improved and without infarction or emergency CABG after 4 months.  相似文献   
6.
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号